A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
- PMID: 37228009
- PMCID: PMC10212100
- DOI: 10.1371/journal.ppat.1011370
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
Erratum in
-
Correction: A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?PLoS Pathog. 2024 Jan 29;20(1):e1011503. doi: 10.1371/journal.ppat.1011503. eCollection 2024 Jan. PLoS Pathog. 2024. PMID: 38285967 Free PMC article.
Abstract
VAR2CSA is the Plasmodium falciparum variant surface antigen that mediates binding of infected erythrocytes to chondroitin sulfate A (CSA) and their sequestration in intervillous spaces of the placenta, leading to placental malaria (PM). Relatively high polymorphism in VAR2CSA sequences has hindered development of a vaccine that induces broadly neutralizing immunity. Recent research has highlighted that a broadly reactive human monoclonal antibody, called PAM1.4, binds to multiple conserved residues of different subfragments of VAR2CSA, forming a conformational epitope. In this short perspective, we describe evidence that residues located in the interdomain-1 fragment of VAR2CSA within the PAM1.4 binding epitope might be critical to broad reactivity of the antibody. Future investigation into broadly reactive anti-VAR2CSA antibodies may be important for the following: (1) identification of similar conformation epitopes targeted by broadly neutralizing antibodies; and (2) understanding different immune evasion mechanisms used by placenta-binding parasites through VAR2CSA polymorphism in critical epitopes.
Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Conflict of interest statement
The authors declare no competing interests are associated with this manuscript submission.
Figures

Similar articles
-
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.Elife. 2022 Feb 1;11:e76264. doi: 10.7554/eLife.76264. Elife. 2022. PMID: 35103596 Free PMC article.
-
Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA.PLoS Pathog. 2022 Nov 16;18(11):e1010924. doi: 10.1371/journal.ppat.1010924. eCollection 2022 Nov. PLoS Pathog. 2022. PMID: 36383559 Free PMC article.
-
Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.J Immunol. 2010 Dec 15;185(12):7553-61. doi: 10.4049/jimmunol.1002390. Epub 2010 Nov 15. J Immunol. 2010. PMID: 21078904 Free PMC article.
-
Designing a VAR2CSA-based vaccine to prevent placental malaria.Vaccine. 2015 Dec 22;33(52):7483-8. doi: 10.1016/j.vaccine.2015.10.011. Epub 2015 Nov 26. Vaccine. 2015. PMID: 26469717 Free PMC article. Review.
-
Progress and Insights Toward an Effective Placental Malaria Vaccine.Front Immunol. 2021 Feb 25;12:634508. doi: 10.3389/fimmu.2021.634508. eCollection 2021. Front Immunol. 2021. PMID: 33717176 Free PMC article. Review.
Cited by
-
Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.J Infect Dis. 2025 Jun 2;231(5):e956-e965. doi: 10.1093/infdis/jiae529. J Infect Dis. 2025. PMID: 39585195 Free PMC article.
-
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum.Biomolecules. 2024 Jan 12;14(1):100. doi: 10.3390/biom14010100. Biomolecules. 2024. PMID: 38254700 Free PMC article. Review.
-
Correction: A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?PLoS Pathog. 2024 Jan 29;20(1):e1011503. doi: 10.1371/journal.ppat.1011503. eCollection 2024 Jan. PLoS Pathog. 2024. PMID: 38285967 Free PMC article.
-
Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine.Trends Parasitol. 2023 Nov;39(11):929-935. doi: 10.1016/j.pt.2023.08.006. Epub 2023 Sep 6. Trends Parasitol. 2023. PMID: 37684152 Free PMC article. Review.
-
PfEMP1 and var genes - Still of key importance in Plasmodium falciparum malaria pathogenesis and immunity.Adv Parasitol. 2024;125:53-103. doi: 10.1016/bs.apar.2024.02.001. Epub 2024 Mar 23. Adv Parasitol. 2024. PMID: 39095112 Free PMC article. Review.
References
-
- Doritchamou J, Sabbagh A, Jespersen JS, Renard E, Salanti A, Nielsen MA, et al.. Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA. PLoS ONE. 2015;10(9):e0137695. Epub 2015/09/24. doi: 10.1371/journal.pone.0137695 ; PubMed Central PMCID: PMC4579133. - DOI - PMC - PubMed
-
- Otto TD, Assefa SA, Bohme U, Sanders MJ, Kwiatkowski D, Pf3k consortium, et al.. Evolutionary analysis of the most polymorphic gene family in falciparum malaria. Wellcome Open Res. 2019;4:193. Epub 2020/02/15. doi: 10.12688/wellcomeopenres.15590.1 ; PubMed Central PMCID: PMC7001760. - DOI - PMC - PubMed
-
- Clausen TM, Christoffersen S, Dahlback M, Langkilde AE, Jensen KE, Resende M, et al.. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. J Biol Chem. 2012;287(28):23332–23345. Epub 2012/05/10. doi: 10.1074/jbc.M112.348839 ; PubMed Central PMCID: PMC3390611. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases